Publicaciones en colaboración con investigadores/as de Hospital de Galdakao - Usansolo (17)

2024

  1. Identifying COPD patients with poor health status and low exercise tolerance through the five-repetition sit-to-stand test and modified Medical Research Council Dyspnea Score

    European Journal of Internal Medicine, Vol. 125, pp. 51-56

  2. Potential protective role of let-7d-5p in atherosclerosis progression reducing the inflammatory pathway regulated by NF-κB and vascular smooth muscle cells proliferation

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 7

2023

  1. Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population

    Archivos de Bronconeumologia, Vol. 59, Núm. 12, pp. 842-845

2022

  1. Validation of the Spanish Activity Questionnaire in COPD (SAQ-COPD) in Patients with Chronic Obstructive Pulmonary Disease

    International Journal of COPD, Vol. 17, pp. 2835-2846

2020

  1. A multidrug-resistant microorganism infection risk prediction model: development and validation in an emergency medicine population

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 39, Núm. 2, pp. 309-323

2019

  1. Erratum to “Spanish Clinical Guidelines on Vascular Access for Haemodialysis” [(NEFROLOGÍA) (2019) 39(1) (1–2), (S0211699518301048), (10.1016/j.nefro.2018.07.001)]

    Nefrologia

  2. Erratum: Fe de errores de Guía Clínica Española del Acceso Vascular para Hemodiálisis (Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia (2017) 37 Suppl 1 (1-191) PII: S0211-6995(19)30153-5)

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia

  3. Erratum: Fe de errores de «Guía Clínica Española del Acceso Vascular para Hemodiálisis» (Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia (2017) 37 Suppl 1 (1-191) PII: S0211-6995(18)30104-8)

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia

  4. Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study

    Respiratory Medicine, Vol. 151, pp. 49-54

2018

  1. Cost of hospitalizations due to exacerbation in patients with non-cystic fibrosis bronchiectasis

    Respiration, Vol. 96, Núm. 5, pp. 406-416

  2. Creation of the SAQ-COPD Questionnaire to Determine Physical Activity in COPD Patients in Clinical Practice

    Archivos de Bronconeumologia, Vol. 54, Núm. 9, pp. 467-475

2017

  1. The variability of respiratory symptoms and associated factors in COPD

    Respiratory Medicine, Vol. 129, pp. 165-172

2016

  1. Key issues in the infected patient care in the Emergency Department

    Revista Espanola de Quimioterapia, Vol. 29, Núm. 6, pp. 318-327

2015

  1. What pulmonologists think about the asthma–COPD overlap syndrome

    International Journal of COPD, Vol. 10, pp. 1321-1330

2014

  1. Multicentric study on the beta-blocker use and relation with exacerbations in COPD

    Respiratory Medicine, Vol. 108, Núm. 5, pp. 737-744

2012

  1. Consensus Document on the Overlap Phenotype COPD-Asthma in COPD

    Archivos de Bronconeumologia, Vol. 48, Núm. 9, pp. 331-337

2001

  1. Prevalencia de los Aneurismas de Aorta Abdominal Infrarrenal en pacientes con Arteriopatía Obstructiva Crónica de Extremidades Inferiores

    Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 98, Núm. 2, pp. 33-42